What is EverlyWell?
Founded in 2015 and based in Austin, TX, Everlywell is a health and wellness company that empowers consumers with at-home lab testing kits. The company facilitates connections between users and certified lab partners, delivering digital results for a wide array of tests, including those for food sensitivities, fertility, STDs, and thyroid function. Everlywell's innovative approach democratizes health diagnostics, making personalized health insights readily available.
How much funding has EverlyWell raised?
EverlyWell has raised a total of $304.5M across 5 funding rounds:
Angel/Seed
$2.5M
Angel/Seed
$2M
Unspecified
$50M
Series D
$175M
Private Equity
$75M
Angel/Seed (2016): $2.5M, investors not publicly disclosed
Angel/Seed (2017): $2M led by Full Tilt Capital, Jack Novak, SoGal Ventures, and NextGen Venture Partners
Unspecified (2019): $50M supported by SoGal Ventures, Highland Capital Partners, NextGen Venture Partners, Next Coast Ventures, and Goodwater Capital
Series D (2020): $175M featuring The Chernin Group, Greenspring Associates, Lux Capital, Foresite Capital, Goodwater Capital, Portfolia, BlackRock, Highland Capital Partners, Morningside Ventures, and Next Coast Ventures
Private Equity (2021): $75M backed by HealthQuest Capital
Key Investors in EverlyWell
SoGal Ventures
SoGal Ventures is a venture capital firm that supports diverse entrepreneurs, focusing on early-stage investments outside of Silicon Valley. They back next-gen billion-dollar businesses that prioritize societal and environmental benefits, with a portfolio including companies in healthcare and community solutions.
NextGen Venture Partners
NextGen Partners is an organization dedicated to the professional development and networking of emerging Venture Capital investors, fostering growth and relationships within the industry.
Highland Capital Partners
Highland Capital Partners is a venture capital firm that invests in entrepreneurs and innovative startups, with a significant track record of successful exits and IPOs, managing substantial assets under management.
What's next for EverlyWell?
The substantial enterprise-level funding Everlywell has garnered, culminating in its recent major strategic investment, positions the company for accelerated expansion and innovation. This capital infusion is expected to fuel further development of its testing portfolio, enhance its digital platform, and broaden its market reach. As Everlywell continues to scale, its focus will likely remain on leveraging technology to improve health outcomes and provide consumers with actionable data for proactive wellness management. The company's trajectory suggests a strong future in the evolving landscape of personalized health.
See full EverlyWell company page
